ASX:ANN - Ansell Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started A$23.73 +0.74 (+3.22 %) (As of 01/23/2019 04:00 PM ET)Previous CloseA$22.99Today's RangeA$23.06 - A$23.9052-Week RangeA$20.30 - A$26.46Volume1.40 million shsAverage Volume739,509 shsMarket Capitalization$3.15 billionP/E Ratio7.15Dividend Yield2.97%BetaN/A ProfileDiscussionChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, Caribbean, and North America. It operates through two segments, Healthcare and Industrial. The Healthcare segment offers a range of surgical and examination gloves covering various applications; and healthcare safety devices and active infection protection products for healthcare patients. This segment's products include medical exam gloves, general disposable gloves, surgical gloves, event protection and sharps safety products, O.R. turnover solutions, patient positioners, staff and patient ergonomics, silver barrier dressings, outer dressings, medical specialty gloves, safety essentials, and fluid and trip management products, as well as burn and wound care products. It also distributes single use gloves used in industrial applications, including chemical, food services, life sciences, electronics, and automotive aftermarket. This segment offers its products under the Microflex, SANDEL, MICROTOUCH, GAMMEX, ENCORE, ANSELL MEDICAL, MEDI-GRIP, TouchNTuff, and Marigold brands for acute care hospitals, emergency services, alternate care, and dentistry and veterinary clinics. The Industrial segment provides hand, foot, and body protection solutions for industrial worker environments and specialty applications, including the automotive, chemical, food processing, life sciences, machinery and equipment, metal fabrication, mining, and oil and gas industries. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1888 and is based in Richmond, Australia. Receive ANN News and Ratings via Email Sign-up to receive the latest news and ratings for ANN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ASX Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolASX:ANN Previous Symbol CUSIPN/A Webwww.ansell.comen.aspx Phone+61-3-92707270Debt Debt-to-Equity Ratio35.61 Current Ratio3.85 Quick Ratio2.62Price-To-Earnings Trailing P/E Ratio7.15 Forward P/E Ratio21.00 P/E Growth2.46 Sales & Book Value Annual Sales$1.49 billion Price / Sales2.11 Cash FlowA$4.10 per share Price / Cash Flow5.79 Book ValueA$10.79 per share Price / Book2.20Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees12,482 Outstanding Shares132,655,000Market Cap$3.15 billion OptionableNot Optionable Ansell (ASX:ANN) Frequently Asked Questions What is Ansell's stock symbol? Ansell trades on the ASX under the ticker symbol "ANN." Has Ansell been receiving favorable news coverage? Press coverage about ANN stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ansell earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the company's share price in the immediate future. Who are some of Ansell's key competitors? Some companies that are related to Ansell include Advanced Medical Solutions (AMS), Akers Biosciences (AKR), ANSELL LTD/S (ANSLY), Bovie Medical (BVX), Bovie Medical (BVX), Clover (CLV), CONVATEC GRP PL/ADR (CNVVY), CRH Medical (CRHM), CRH Medical (CRH), Daxor (DXR), Enerplus (ERF), Essilor International Cmgn Gnl D Optq (EI), Gerresheimer (GXI), InfuSystem (INFU) and Iris BioTechnologies (IRSB). Who are Ansell's key executives? Ansell's management team includes the folowing people: Mr. Magnus R. Nicolin, MD, CEO & Exec. Director (Age 61)Mr. Neil I. Salmon BA, ACMA, Chief Financial Officer (Age 49)Mr. Steve Genzer BSc, MBA, Pres of IGBUMr. Joeseph Kubicek BA, MBA, Pres of HGBUMr. Darryl Nazareth BS, MS, MBA, Sr. VP of Operations and R&D What is Ansell's stock price today? One share of ANN stock can currently be purchased for approximately A$23.73. How big of a company is Ansell? Ansell has a market capitalization of $3.15 billion and generates $1.49 billion in revenue each year. Ansell employs 12,482 workers across the globe. What is Ansell's official website? The official website for Ansell is http://www.ansell.com/en.aspx. How can I contact Ansell? Ansell's mailing address is L 3 678 Victoria St, RICHMOND, VIC 3121, Australia. The company can be reached via phone at +61-3-92707270. MarketBeat Community Rating for Ansell (ASX ANN)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 109 (Vote Outperform)Underperform Votes: 169 (Vote Underperform)Total Votes: 278MarketBeat's community ratings are surveys of what our community members think about Ansell and other stocks. Vote "Outperform" if you believe ANN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment?